SciELO - Scientific Electronic Library Online

 
vol.140 número2Linfomas primarios de testículo: Análisis clínicopatológico de 10 casos. Experiencia en el Instituto Nacional de Cancerología índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Gaceta médica de México

versión On-line ISSN 2696-1288versión impresa ISSN 0016-3813

Resumen

CASTANEDA MENDOZA, Roberto et al. Seguimiento a largo plazo en 413 pacientes con vía accesoria atrioventricular sometidos a ablación con radiofrecuencia. Gac. Méd. Méx [online]. 2004, vol.140, n.2, pp.117-121. ISSN 2696-1288.

Objective: the aim of this study was shown clinical characteristics and follow-up of patients with atrioventricular reentrant tachycardia (AVRT) who underwent radiofrequency catheter ablation (RCA) therapy. Material and Methods: from April 1992 to December 1995, 413 patients with AVRT underwent RCA therapy. Results: two hundred thirty four men (57%) and one hundred seventy nine women (43%) aged 31.3 ± 16-3 years were studied. 437 single accessory pathways were found; 24 had multiple accessory pathways. Ablation therapy was successful in 381 accessory pathways. During follow-up of 7 years, AVRT recurred in 51 patients (13%) and in 80% this occurred within the first 3 months after the procedure. 56 patients underwent a second RCA therapy with success in 35 patients (83.5); two reoccurred (5.7%); 365 accessory pathways (83.5) remained without evidence of preexcitation AVRT. Conclusions: during follow-up, these patients with successful ablation therapy remained without symptoms. In patients who underwent a second RCA therapy, atrioventricular reentrant mechanism was always present.

Palabras llave : Radiofrequency catheter ablation; supraventricular tachycardia; accessory pathway.

        · resumen en Español     · texto en Español

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons